EyePoint Pharmaceuticals, Inc.
Headquarters Watertown, MA
Financials
Prospectuses and Registrations
FORMNAMEDATE FILED
424B5Prospectus11/6/2025424B5Prospectus10/16/2025FWPFiling under Securities Act Rules 163/433 of free writing prospectuses10/15/2025424B5Prospectus10/14/2025S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuers10/14/2025S-8Securities to be offered to employees in employee benefit plans8/7/2025424B5Prospectus10/30/2024
Proxies
FORMNAMEDATE FILED
DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material5/9/2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material4/28/2025DEF 14AOther definitive proxy statements4/28/2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material4/26/2024DEF 14AOther definitive proxy statements4/26/2024DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material4/28/2023DEF 14AOther definitive proxy statements4/28/2023
News
FORMNAMEDATE FILED
8-KRegulation FD Disclosure3/20/20268-KResults of Operations and Financial Condition3/4/20268-KNews Release3/2/20268-KResults of Operations and Financial Condition1/7/20268-KAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year12/8/20258-KNews Release11/19/20258-KNews Release11/6/2025
Ownership